#clinical #investment
Drug, Pharmaceutical drug, Pharmacology, Clinical trial, Pre-clinical development, Pharmaceutical industry
RedX Pharma CEO focuses on pipeline that found Lilly’s rising star
RT @AlderleyPark: Great @pharmaphorum read ft. @RedxPharma's CEO 👉 "Thanks to the new #investment, plus partnerships with @AstraZeneca & @JazzPharma, the company is well positioned to develop two promising #clinical stage drugs in-house, at least until the end of phase 2." https://t.co/R4ByIzznXH
OpenBack in 2017, the UK biotech RedX Pharma had to sell off its prized asset after administrators stepped in to stave off a debt crisis, with Loxo Oncology snapping up the BTK inhibitor for $40 million.
RT @AlderleyPark: Great @pharmaphorum read ft. @RedxPharma's CEO 👉 "Thanks to the new #investment, plus partnerships with @AstraZeneca & @JazzPharma, the company is well positioned to develop two promising #clinical stage drugs in-house, at least until the end of phase 2." https://t.co/R4ByIzznXH
OpenRedX Pharma CEO focuses on pipeline that found Lilly’s rising star
Back in 2017, the UK biotech RedX Pharma had to sell off its prized asset after administrators stepped in to stave off a debt crisis, with Loxo Oncology snapping up the BTK inhibitor for ...
We are sorry, we could not find the related article
If you are curious about Biotech Essentials, the Influencers Review and Biotech & Healthcare
Please click on:
Or signup to our newsletters
Redx shares soar after IPF drug licence deal with AstraZeneca
Shares in Redx Pharma were soaring this morning after it licensed its preclinical fibrotic diseases drug to AstraZeneca.
Small Pharma Driving Big Pharma Innovation
The Path to R&D Innovation Lies in the Power of Small Pharma
Big pharma is using AI and machine learning in drug discovery and development to save lives
Insider Intelligence details how AI and machine learning can help at every stage of the drug discovery process, from research to clinical trials.
AstraZeneca
[3] It has Research and development concentrated in three strategic centres; Cambridge, Gothenburg, Sweden and Gaithersburg, U.S.[4] AstraZeneca has a portfolio of products for major ...
Struggling Redx out-licenses fibrotic asset to AstraZeneca, sees stock sky rocket
AstraZeneca is picking up a delayed preclinical fibrosis candidate from RedX in a deal that gives the U.K. biotech a much needed cash boost which also saw its shares sky rocket.
Redx snags potential $377M deal with Astrazeneca for fibrosis-targeting RXC-006
LONDON – Redx Pharma plc is in the process of handing its RXC-006 program over to Astrazeneca plc, after signing a potential $377 million development and commercialization deal for the ...
Deep Dive Into Big Pharma AI Productivity: One Study Shaking The Pharmaceutical Industry
The pharmaceutical business is perhaps the only industry on the planet, where to get the product from idea to market the company needs to spend about a decade, several billion dollars, and ...
Bayer hands over a big drug R&D operation to CRO amid an ongoing restructuring effort
Bayer’s 400-strong small molecule R&D team is being carved out and handed to a CRO, where they’ll continue to work for Bayer. The pharma player — which has been steadily finding ways to ...
Hunting for New Drugs with AI
The pharmaceutical industry is in a drug-discovery slump. How much can AI help?
The billion-dollar race to change how drugs are made
Alphabet’s AI lab DeepMind is proving that artificial intelligence can be game-changing for drug discovery. Could savvy upstarts upend Big Pharma?
Innovation Supports Growth at Big Pharma/Big Biotech Companies
Moats and returns on invested capital look stable for companies with a solid list of pipeline drugs.
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
It’s October: a time of days growing shorter, leaves changing color, and phone calls in the wee hours that rouse scientists from slumber notifying them
Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19
Canadian drug discovery technology company AbCellera, which analyzes and identifies antibodies for pharmaceutical companies working on a coronavirus treatment and other medicines, said on ...
Drug research turns to artificial intelligence in COVID-19 fight
Tech company locks down government funding to repurpose drugs for virus treatment
How the Pharma Industry Pulled Off the Pivot to COVID-19
The urgent need for tests and therapeutics has brought companies together and pushed researchers to work at breakneck speeds.
Negative Perceptions Of Biopharma — Let's Get The Ugly On The Table
A Life Science Leader reader shares their thoughts on why the biopharmaceutical industry’s reputation is so dismal, but also proposes solutions ...